PDL BioPharma, Inc. EPS (Diluted, from Disc. Ops)

EPS (Diluted, from Disc. Ops) of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Diluted, from Disc. Ops) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Diluted, from Disc. Ops) for the quarter ending June 29, 2020 was $-0.32 (a -Infinity% decrease compared to previous quarter)
  • Year-over-year quarterly EPS (Diluted, from Disc. Ops) decreased by -366.67%
  • Twelve month EPS (Diluted, from Disc. Ops) ending June 29, 2020 was $-0.17
Trailing EPS (Diluted, from Disc. Ops) for the last four month:
29 Jun '20
$-0.17
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Diluted, from Disc. Ops) of PDL BioPharma, Inc.

Most recent EPS (Diluted, from Disc. Ops)of PDLI including historical data for past 10 years.

Interactive Chart of EPS (Diluted, from Disc. Ops) of PDL BioPharma, Inc.

PDL BioPharma, Inc. EPS (Diluted, from Disc. Ops) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.0 $0.0
2019 $0.0 $0.0

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.